Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;51(8):1286-1291.
doi: 10.1111/imj.14884.

Strongyloides stercoralis seropositivity is not associated with increased symptoms in a remote Aboriginal community

Martin Hansen  1 , Emily Bowden  2 , Bart J Currie  1   2 , Linda Ward  2 , Ross M Andrews  2   3 , Roslyn Gundjirryirr Dhurrkay, George Garambaka Gurruwiwi, Therese Kearns  2
Affiliations

Strongyloides stercoralis seropositivity is not associated with increased symptoms in a remote Aboriginal community

Martin Hansen et al. Intern Med J. 2021 Aug.

Abstract

Background: Strongyloides stercoralis is a soil-transmitted helminth, endemic in remote Aboriginal and Torres Strait Islander communities in northern Australia with estimates of prevalences up to 60%. Hyperinfection in the setting of immunosuppression is a rare, but well recognised cause of significant morbidity and mortality. However, the morbidity associated with chronic uncomplicated infection is less well characterised.

Aims: To measure the prevalence of symptoms potentially attributable to S. stercoralis infection and their association with seropositivity.

Methods: This retrospective matched case-control study reviewed records of primary healthcare presentations for symptoms in the 12 months before and after an ivermectin mass drug administration (MDA) in a remote Aboriginal community.

Results: One hundred and seventy-five S. stercoralis seropositive cases were matched with 175 seronegative controls. The most frequently reported symptom overall in the 12 months prior to the MDA was cough followed by abdominal pain, weight loss/malnutrition, diarrhoea and pruritis. Seropositive cases were not more likely than matched controls to have symptoms typically attributed to strongyloidiasis. In the seropositive cohort, we found no difference in symptoms in the 12 months before and after an ivermectin MDA despite a reduction in seroprevalence.

Conclusion: We found no evidence to suggest that S. stercoralis seropositivity was associated with increased symptoms when compared to matched seronegative controls. Treatment with ivermectin did not reduce symptoms in seropositive cases. Without evidence to support that population-based screening or treatment programmes reduce symptoms, the emphasis must remain on identifying and managing those few individuals with immunosuppression that predisposes them to potentially life-threatening hyperinfection.

Keywords: Strongyloides stercoralis; epidemiology; mass drug administration; neglected diseases; rural health; strongyloidiasis.

PubMed Disclaimer

Comment in

  • Author reply.
    Hansen M, Currie BJ. Hansen M, et al. Intern Med J. 2021 Dec;51(12):2162. doi: 10.1111/imj.15613. Intern Med J. 2021. PMID: 34939282 No abstract available.
  • Strongyloidiasis does not discriminate: nor should the screening and treatment.
    Cooper-Beknazarova M, White M, Whiley H, Gray DJ, Mutombo PN, Bradbury R, McManus D, Gordon C, Judd J, Ross KE. Cooper-Beknazarova M, et al. Intern Med J. 2021 Dec;51(12):2160-2161. doi: 10.1111/imj.15579. Intern Med J. 2021. PMID: 34939286 No abstract available.

References

    1. Puthiyakunnon S, Boddu S, Li Y, Zhou X, Wang C, Li J et al. Strongyloidiasis - an insight into its global prevalence and management. PLoS Negl Trop Dis 2014; 8: e3018.
    1. Johnston FH, Morris PS, Speare R, McCarthy J, Currie B, Ewald D et al. Strongyloidiasis: a review of the evidence for Australian practitioners. Aust J Rural Health 2005; 13: 247-54.
    1. Kearns TM, Currie BJ, Cheng AC, McCarthy J, Carapetis JR, Holt DC et al. Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community. PLoS Negl Trop Dis 2017; 11: e0005607.
    1. Hays R, Esterman A, McDermott R. Control of chronic Strongyloides stercoralis infection in an endemic community may be possible by pharmacological means alone: results of a three-year cohort study. PLoS Negl Trop Dis 2017; 11: e0005825.
    1. Paltridge M, Smith S, Traves A, McDermott R, Fang X, Blake C et al. Rapid progress towards elimination of strongyloidiasis in North Queensland, tropical Australia. Am J Trop Med Hyg 2020; 102: 339-45.